Collegium to Present at Upcoming Investor Conferences
May 23, 2017 11:52 am UTC| Business
CANTON, Mass., May 23, 2017 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that management will present at the following investor conferences in June: The Jefferies 2017 Global Healthcare Conference...
Quantum Materials Granted Patent, Honored By Gartner as 2017 Cool Vendor in 3D Printing
May 23, 2017 11:35 am UTC| Business
SAN MARCOS, Texas, May 23, 2017 -- Quantum Materials Corp (OTCBB:QTMM) today announced that the United States Patent and Trademark Office has granted Quantum Materials Corp Patent # 9577149 for the continuous synthesis...
May 23, 2017 11:33 am UTC| Business
Contribution of single agents in the combination regimen successfully established pursuant to the UNITY-CLL Special Protocol Assessment; DSMB recommends no further enrollment to single agent arms DSMB reviewed updated...
May 23, 2017 11:33 am UTC| Business
Contribution of single agents in the combination regimen successfully established pursuant to the UNITY-CLL Special Protocol Assessment; DSMB recommends no further enrollment to single agent arms DSMB reviewed updated...
May 23, 2017 11:33 am UTC| Business
Contribution of single agents in the combination regimen successfully established pursuant to the UNITY-CLL Special Protocol Assessment; DSMB recommends no further enrollment to single agent arms DSMB reviewed updated...
May 23, 2017 11:33 am UTC| Business
Contribution of single agents in the combination regimen successfully established pursuant to the UNITY-CLL Special Protocol Assessment; DSMB recommends no further enrollment to single agent arms DSMB reviewed updated...
May 23, 2017 11:33 am UTC| Business
CARMIEL,Israel, May 23, 2017 -- Protalix BioTherapeutics, Inc.(NYSE:PLX) (TASE:PLX), announced today that an oral presentation highlighting the results from the Company’s phase II clinical trial of alidornase alfa...